MedPage Today October 30, 2024
— COVID highlighted the untapped potential of existing treatments
As COVID-19 rapidly evolved from an outbreak to a pandemic, researchers, clinicians, governments, and the public were all desperately seeking solutions. In the setting of this urgency, drug repurposing emerged as a powerful strategy for identifying potential treatments — utilizing medications already available on pharmacy shelves around the world.
Some proved effective, while others did not. In the end, it was the lesser-known repurposed drugs that received far less attention that ended up saving the most lives: dexamethasone, tocilizumab (Actemra), and baricitinib (Olumiant). These drugs quietly saved, and continue to save, countless lives, demonstrating the immense potential of repurposing to unlock additional life-saving uses of existing drugs.
We believe that the...
Today's Sponsors
Today's Sponsor